Q2 2023 Holdings
Filed 2023-08-14 | 198 holdings | $7.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $386.1M | 1,097,166 | 5.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $384.9M | 9,380,300 | 5.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $359.8M | 923,284 | 5.1% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $288.0M | 842,224 | 4.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $246.4M | 2,612,800 | 3.5% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $202.7M | 3,201,800 | 2.9% |
| Moderna Inc(MRNA) | COM | 60770K107 | $185.3M | 1,525,059 | 2.6% |
| Abbott Labs(ABT) | COM | 002824100 | $179.5M | 1,646,501 | 2.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $170.9M | 899,650 | 2.4% |
| Incyte Corp(INCY) | COM | 45337C102 | $164.4M | 2,640,765 | 2.3% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $146.4M | 3,114,375 | 2.1% |
| Stryker Corporation(SYK) | COM | 863667101 | $145.5M | 476,946 | 2.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $144.0M | 2,661,452 | 2.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $127.0M | 4,746,000 | 1.8% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $124.3M | 1,410,492 | 1.8% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $115.9M | 357,020 | 1.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $113.7M | 4,013,500 | 1.6% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $112.2M | 2,223,418 | 1.6% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $104.5M | 3,448,322 | 1.5% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $101.0M | 210,127 | 1.4% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $100.3M | 7,542,829 | 1.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $97.9M | 1,038,092 | 1.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $97.9M | 761,716 | 1.4% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $94.5M | 1,006,772 | 1.3% |
| Insulet Corp(PODD) | COM | 45784P101 | $93.3M | 323,594 | 1.3% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $89.2M | 337,723 | 1.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $80.6M | 234,220 | 1.1% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $77.2M | 270,526 | 1.1% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $74.3M | 2,287,623 | 1.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $69.6M | 3,300,911 | 1.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $68.4M | 3,125,886 | 1.0% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $66.1M | 314,513 | 0.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $61.1M | 1,800,000 | 0.9% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $60.9M | 4,521,059 | 0.9% |
| Align Technology Inc(ALGN) | COM | 016255101 | $60.5M | 171,140 | 0.9% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $57.5M | 114,441 | 0.8% |
| Humana Inc(HUM) | COM | 444859102 | $57.0M | 127,373 | 0.8% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $53.6M | 271,046 | 0.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $52.8M | 2,127,000 | 0.8% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $52.4M | 4,170,800 | 0.7% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $51.4M | 612,613 | 0.7% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $51.4M | 9,609,913 | 0.7% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $51.4M | 2,092,934 | 0.7% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $51.0M | 134,533 | 0.7% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $50.5M | 899,300 | 0.7% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $50.1M | 96,101 | 0.7% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $49.5M | 164,338 | 0.7% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $48.7M | 160,515 | 0.7% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $48.4M | 2,534,000 | 0.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $47.2M | 518,495 | 0.7% |